financetom
Business
financetom
/
Business
/
Alignment Healthcare Insider Sold Shares Worth $3,539,434, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Alignment Healthcare Insider Sold Shares Worth $3,539,434, According to a Recent SEC Filing
Sep 11, 2025 1:20 AM

03:45 AM EDT, 09/11/2025 (MT Newswires) -- Dawn Christine Maroney, President, on September 10, 2025, sold 215,662 shares in Alignment Healthcare ( ALHC ) for $3,539,434. Following the Form 4 filing with the SEC, Maroney has control over a total of 1,797,237 common shares of the company, with 1,797,237 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1832466/000185039725000008/xslF345X05/wk-form4_1757549260.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Jon Stewart Says Apple Asked Him Not to Interview Federal Trade Commission Chair on Podcast
Jon Stewart Says Apple Asked Him Not to Interview Federal Trade Commission Chair on Podcast
Apr 2, 2024
03:48 PM EDT, 04/02/2024 (MT Newswires) -- Apple ( AAPL ) asked comedian Jon Stewart not to interview Federal Trade Commission Chair Lina Khan on a podcast while he was hosting The Problem With Jon Stewart on Apple TV+, Stewart said during an episode of The Daily Show on Monday while interviewing Khan. Stewart's comments came after the US Department...
Onconova Therapeutics Shares Drop; Company to Merge With Trawsfynydd Therapeutics
Onconova Therapeutics Shares Drop; Company to Merge With Trawsfynydd Therapeutics
Apr 2, 2024
03:37 PM EDT, 04/02/2024 (MT Newswires) -- Onconova Therapeutics ( ONTX ) shares fell 4.6% in recent Tuesday trading after the company announced a merger with closely held Trawsfynydd Therapeutics in an all-stock transaction. The combined company will be named Traws Pharma and will begin trading on Nasdaq on Wednesday under the new ticker symbol TRAW. Traws announced that it...
BlueLinx Names Mike Wilson Chief Commercial Officer
BlueLinx Names Mike Wilson Chief Commercial Officer
Apr 2, 2024
03:47 PM EDT, 04/02/2024 (MT Newswires) -- BlueLinx ( BXC ) said Tuesday it appointed Mike Wilson as chief commercial officer. Wilson, formerly chief product management officer at BlueLinx ( BXC ), will now oversee the commercial team, including five regional vice presidents and the vice president of national accounts. Price: 123.83, Change: -4.24, Percent Change: -3.31 ...
Sector Update: Health Care
Sector Update: Health Care
Apr 2, 2024
03:32 PM EDT, 04/02/2024 (MT Newswires) -- Health care stocks were lower late Tuesday afternoon, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) each dropping 1.6%. The iShares Biotechnology ETF (IBB) fell 2.3%. In corporate news, Acorda Therapeutics ( ACOR ) shares were tumbling 81.4%, a day after it signed an agreement to...
Copyright 2023-2026 - www.financetom.com All Rights Reserved